Skip to main content
. 2022 Aug 17;10(8):e004761. doi: 10.1136/jitc-2022-004761

Figure 1.

Figure 1

Kaplan-Meier plots of rPFS and OS in all treated patients and based on HRD status for cohort A1 (A, B) and cohort A2 (C, D). HRD, homologous recombination deficiency; NE, not evaluable; OS, overall survival; rPFS, radiographic progression-free survival.